Clinical Laserthermia Systems Stock: price and insider trades · Sweden
No insider purchase over the last 90 days. The latest, by Thomas Binzer, was filed 01 Jul 2025.
Clinical Laserthermia Systems: what insiders have been doing
Clinical Laserthermia Systems is a listed company. Its insiders report their share dealings to Finansinspektionen. The past year has been quiet: not a single insider filing for Clinical Laserthermia Systems. The previous disclosure was published on 29 September 2025.
The full history, which starts in 2016, counts 21 purchases against 3 sales.
For comparison within the same market, see the insider buying recorded at Dynavox Group AB and Rusta AB (publ). These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Who traded when
BuySaleSince the insiders bought
- -31.2%Entry 272.65 · Close at T+365 187.60
- -38.5%Entry 484.25 · Close at T+365 298.04
- -41.1%Entry 487.18 · Close at T+365 286.87
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
- 68,965 shares@ SEK 3.80100.0% of flowAktieISIN SE0002756130FI:csv-a25755b901952c9a99d4
- 25,600 shares@ SEK 2.898100.0% of flowAktieISIN SE0022242384FI:csv-2788c75a80de8b89bbaeCanonical exit: 29 Sept 2025 (T+90)
- 4,000 shares@ SEK 3.800.7% of flowAktieISIN SE0022049920FI:csv-5b7c4783e2fb67b3b33d
- Interntransaktion – FörvärvISIN Common sharesFI:csv-08bbae1e4a1565ec9048
- AvyttringISIN Common sharesFI:csv-30f412777ba855b9a6a1
- 31,786 shares@ SEK 3.6849.8% of flowBTU (betald tecknad unit)ISIN SE0022049920FI:csv-920d8cb45cf4ae615940
- 12,512 shares@ SEK 3.685.1% of flowAktieISIN SE0022242384FI:csv-3b6c488e782938d73278
- 10,500 shares@ SEK 4.0845.0% of flowAktieFI:csv-2292e821ae2cb4269627Canonical exit: 12 Feb 2025 (T+90)
- 10,000 shares@ SEK 5.2855.0% of flowAktieFI:csv-c515549e32c9b23d40f1Canonical exit: 4 Feb 2025 (T+90)
- 4,000 shares@ SEK 5.33472.3% of flowAktieISIN SE0022242384FI:csv-c1eeb19ffa437d046895Canonical exit: 3 Feb 2025 (T+90)
- 4,000 shares@ SEK 5.052.2% of flowAktieISIN SE0022242384FI:csv-e8ca5bd13cfcc3775e17Canonical exit: 3 Feb 2025 (T+90)
- 4,000 shares@ SEK 5.809.8% of flowAktieISIN SE0022049920FI:csv-a2845d0d7656eece6bfaCanonical exit: 29 Jan 2025 (T+90)
- 20,000 shares@ SEK 1.008.4% of flowTeckningsoptionISIN SE0022242319FI:csv-0622412f5d05e409dcfbCanonical exit: 30 Jan 2025 (T+90)
- 8,000 shares@ SEK 6.002.3% of flowAktieISIN SE0022049920FI:csv-4f7375a2a0dd1c653cb9
- 20,000 shares@ SEK 6.256.0% of flowBTU (betald tecknad unit)ISIN SE0002756130FI:csv-3b98398f466d0d400f72Canonical exit: 26 Sept 2024 (T+90)
- 12,512 shares@ SEK 6.258.8% of flowBTU (betald tecknad unit)ISIN SE0022242384FI:csv-7ad04fcf19b49b2bafa9
- 11,786 shares@ SEK 6.2531.9% of flowBTU (betald tecknad unit)ISIN SE0022242384FI:csv-ef1a25ac7cb1cbc9c11e
- 800,000 shares@ SEK 0.103.9% of flowInterimsaktieISIN SE0002756130FI:csv-ab7c4828b4844eeda714
- 160,000 shares@ SEK 2.5018.2% of flowBTU (betald tecknad unit)ISIN SE0018408387FI:csv-f1bf01710ae3a5f270c6Canonical exit: 4 Oct 2023 (T+90)
- 4,000 shares@ SEK 2.50100.0% of flowBTU (betald tecknad unit)ISIN SE0002756130FI:csv-f3fee735cf65795d3516Canonical exit: 1 Oct 2023 (T+90)
- 63,192 shares@ SEK 2.5017.1% of flowBTU (betald tecknad unit)ISIN SE0002756130FI:csv-0365988f1aa9901bad78
- 54,000 shares@ SEK 2.5064.6% of flowBTU (betald tecknad unit)ISIN SE0020388692FI:csv-94e8719ebdda455dd7ab
- 288,000 shares0Teckningsrätt/UniträttISIN SE0020388684FI:csv-79145108354b4b8851ae
- 150,000 shares@ SEK 0.463.4% of flowInterimsaktieISIN SE0002756130FI:csv-dd6ad08673a000be2357
- 150,000 shares@ SEK 0.4635.4% of flowTeckningsoptionISIN SE0003240787FI:csv-11bdd3791963abf0b730
25 of 52 declarations
About Clinical Laserthermia Systems
Clinical Laserthermia Systems is a company focused on developing laser treatment technologies for cancer. It is listed on the XSTO market.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations